CC
CERE

Corton Capital’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Corton Capital’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,693
Closed -$274K – 695
2024
Q2 		$274K Buy
+6,693
New +$274K 0.14% 229